Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CellSight Technologies

CellSight Technologies
2009 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
2 INVESTORS
Description

Developer of molecular imaging products intended to help in fight against cancer. The company's molecular imaging products images activated T cells and scan early in the treatment cycle can help determine whether a patient's immune system is responding appropriately to their immunotherapy regimen, enabling oncologist to ensure appropriate immune response for patients thereby increasing immunotherapy efficacy.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • 185 Berry Street
  • Suite 350
  • San Francisco, CA 94107
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CellSight Technologies’s full profile, request a free trial.

CellSight Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

CellSight Technologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0

CellSight Technologies Executive Team (3)

Name Title Board
Seat
Contact
Info
Aruna Gambhir Chief Executive Officer
Samuel Quezada Co-Founder & Chief Operating Officer
Shahriar Yaghoubi Ph.D Chief Scientific Officer